Camostat mesylate
-
Catalog numberB2145-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_name4-[[4-[(Aminoiminomethyl)amino]benzoyl]oxy]benzeneacetic acid 2-(dimethylamino)-2-oxoethyl ester methanesulfonate; FOY305
-
DescriptionCamostat mesylate is a synthetic, orally bioavailable is a serine protease inhibitor. Used for the treatment of chronic pancreatitis. It attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity.
-
CAS Number59721-29-8
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₀H₂₂N₄O₅.CH₃SO₃H
-
Molecular Weight494.52
-
Cell PermeableYes
-
Purity≥97% by HPLC
-
SolubilitiesDMSO (>40 mg/ml) or H₂O (>40 mg/ml)
-
HandlingProtect from air and moisture
-
Tag LineA serine protease inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD00941410
-
PubChem CID5284360
-
SMILESCN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N.CS(=O)(=O)O
-
InChiInChI=1S/C20H22N4O5.CH4O3S/c1-24(2)17(25)12-28-18(26)11-13-3-9-16(10-4-13)29-19(27)14-5-7-15(8-6-14)23-20(21)22;1-5(2,3)4/h3-10H,11-12H2,1-2H3,(H4,21,22,23);1H3,(H,2,3,4)
-
InChi KeyFSEKIHNIDBATFG-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameCamostat mesylate
-
Alternative nameCamostat mesylate
-